Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: A cross-sectional observational study

International Journal of Women's Health

Volumn 5, Issue 1, 2013, Pages 93-100

  Sabry, Mohamed ^a,b   Halder, Sunil K ^b   Ait Allah, Abdou S Ait ^a   Roshdy, Eman ^b,c   Rajaratnam, Veera ^b   Al Hendy, Ayman ^b  

^a Sohag University   (Egypt)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c SOHAG UNIVERSITY   (Egypt)

Author keywords

Premenopausal women; Race ethnicity; Risk factor; Vitamin D defciency

Indexed keywords

COLECALCIFEROL;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; RACE DIFFERENCE; RADIOIMMUNOASSAY; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME; UTERUS MYOMA; VITAMIN BLOOD LEVEL;

EID: 84874528706     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S38800     Document Type: Article

References (49)

1. Buttram VC Jr. Uterine leiomyomata: aetiology, symptomatology and management. Prog Clin Biol Res. 1986;225:275-296.
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100-107.
3. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90(6):967-973.
4. Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293-298.
5. Csatlos E, Rigó J Jr, Szabó I, Nagy Z, Joó JG. [Uterine leiomyoma]. Orv Hetil. 2010;151(42):1734-1741. Hungarian.
6. Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR. 2009;30(2):91-104.
7. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211. e1-9.
8. Al-Hendy A, Salama S. Gene therapy and uterine leiomyoma: a review. Hum Reprod Update. 2006;12(4):385-400.
9. Ezzati M, Norian JM, Segars JH. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Womens Health (Lond Engl). 2009;5(4):413-421.
10. Hassan MH, Othman EE, Hornung D, Al-Hendy A. Gene therapy of benign gynecological diseases. Adv Drug Deliv Rev. 2009;61(10): 822-835.
11. Hassan MH, Salama SA, Zhang D, et al. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model. Fertil Steril. 2010;93(1):239-250.
12. Zhang D, Al-Hendy M, Richard-Davis G, et al. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol. 2010;202(3):289. e1-9.
13. Hassan MH, Fouad H, Bahashwan S, Al-Hendy A. Towards nonsurgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model. Hum Reprod. 2011;26(11):3008-3018.
14. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010;235(9):1034-1045.
15. Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fbrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96(4):E754-E762.
16. Bikle DD. Vitamin D: an ancient hormone. Exp Dermatol. 2011;20(1): 7-13.
17. Zhang X, Nicosia S V, Bai W. Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets. 2006;6(3): 229-244.
18. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289(1):F8-F28.
19. McDonnell D P, Mangelsdorf DJ, Pike J W, Haussler MR, O'Malley BW. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science. 1987;235(4793):1214-1217.
20. Vienonen A, Miettinen S, Blauer M, et al. Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig. 2004;11(2):104-112.
21. Feng L, Jayes FL, Jung SH, Leppert PC. Vitamin D receptor (VDR) is over-expressed in the center of uterine fibroids. Fertil Steril. 2010;94(4): S75.
22. Ylikomi T, Laaksi I, Lou YR, et al. Antiproliferative action of vitamin D. Vitam Horm. 2002;64:357-406.
23. Wang QM, Jones JB, Studzinski G P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996;56(2): 264-267.
24. Zhuang SH, Burnstein KL. Antiproliferative effect of 1alpha, 25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology. 1998;139(3):1197-1207.
25. Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol- O-methyltransferase. Fertil Steril. 2011;95(1):247-253.
26. Halder SK, Sharan C, Al-Hendy A. Vitamin D treatment induces dramatic shrinkage of uterine leiomyomas growth in the Eker rat model. Biol Reprod. In press 2012; BOR papers in press. Online Feb 2012, DOI:10.1095/biolreprod.111.098145.
27. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37(10):867-874.
28. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009; 42(15):1549-1556.
29. Horst RL. Exogenous versus endogenous recovery of 25-hydroxyvitamins D2 and D3 in human samples using high-performance liquid chromatography and the DiaSorin LIAISON Total-D Assay. J Steroid Biochem Mol Biol. 2010;121(1-2):180-182.
30. Bläuer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009;91(5):1919-1925.
31. Arabi A, Rassi RE, El-Hajj Fuleihan G. Hypovitaminosis in developing countries. Nat Rev Endocrinol. 2010;6(10):550-561.
32. Henn BM, Botigué LR, Gravel S, et al. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet. 2012;8(1): e1002397.
33. Sánchez-Quinto F, Botigué LR, Civit S, et al. North African populations carry the signature of admixture with Neandertals. PLoS One. 2012; 7(10):e47765.
34. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167(11):1159-1165.
35. Lauretani F, Maggio M, Valenti G, Dall'aglio E, Ceda G P. Vitamin D in older population: new roles for this 'classic actor'? Aging Male. 2010;13(4):215-232.
36. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptoralpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006;86(3):686-693.
37. Csokmay JM, Hill MJ, Maguire M, Payson MD, Fujimoto VY, Armstrong AY. Are there ethnic differences in pregnancy rates in African-American versus white women undergoing frozen blastocyst transfers? Fertil Steril. 2011;95(1):89-93.
38. Peiris AN, Bailey BA, Peiris P, Copeland RJ, Manning T. Race and vitamin D status and monitoring in male veterans. J Natl Med Assoc. 2011;103(6):492-497.
39. Forrest K Y, Stuhldreher WL. Prevalence and correlates of vitamin D defciency in US adults. Nutr Res. 2011;31(1):48-54.
40. Rostand SG. Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis. Clin J Am Soc Nephrol. 2010;5(9):1697-1703.
41. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc. 2010;11(9):617-628.
42. Halder SK, Goodwin S, Al-Hendy A. Vitamin D exhibits antiestrogenic effects in human uterine leiomyoma cells. Fertil Steril. 2010;94(4): S219-S220.
43. Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin D3 regulates steroid hormone functions in human uterine leiomyoma cells. Fertil Steril. 2011;96(3):S149.
44. Nair S, Al-Hendy A. Adipocytes enhance the proliferation of human leiomyoma cells via TNF-α proinfammatory cytokine. Reprod Sci. 2011;18(12):1186-1192.
45. Marshall LM, Spiegelman D, Manson JE, et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 1998;9(5):511-517.
46. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001; 153(1):1-10.
47. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76(1):187-192.
48. Meems LM, Cannon M V, Mahmud H, et al. The vitamin D receptor activator paricalcitol prevents fbrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol. 2012; 132(3-5):282-289.
49. Shroff R, Knott C, Rees L. The virtues of vitamin D: but how much is too much? Pediatr Nephrol. 2010;25(9):1607-1620.